Haemonetics Corporation
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.93 | -0.01 | 1.25 | -0.53 | 0.95 | 0.86 | 2.36 | 0.36 | 2.34 | 1.99 | 1.53 | 1.14 | 7.18 | |
| 0.45 | 0.46 | 0.54 | 0.57 | 0.57 | 0.57 | 0.57 | 0.59 | 0.59 | 0.58 | 0.59 | 0.59 | 2.41 | |
| 0.13 | 0.14 | 0.14 | 0.15 | 0.13 | 0.16 | 0.14 | 0.19 | 0.16 | 0.17 | 0.20 | 0.20 | 0.74 | |
| 0.37 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.61 | -1.30 | 0.24 | -1.60 | -0.53 | -0.70 | 0.83 | -1.15 | 0.55 | 0.25 | -0.13 | -0.15 | 0.55 | |
| 0.48 | 0.43 | 0.19 | 0.11 | 0.18 | 0.17 | 0.32 | 0.08 | 0.11 | 0.14 | 0.38 | 0.17 | 0.81 | |
| -0.49 | -5.23 | -0.25 | -2.70 | -0.46 | -0.34 | 0.36 | -0.68 | -0.64 | -0.63 | -1.87 | -0.49 | -3.69 | |
| 0.07 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.08 | -0.11 | -0.11 | -0.19 | -1.46 | -0.19 | -3.03 | -0.10 | -1.57 | 1.60 | -2.16 | -0.08 | -2.26 | |
| -0.07 | – | – | – | 0.00 | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 | -1.13 | -1.23 | |
| -0.14 | 2.13 | -1.24 | 6.47 | -1.46 | 0.03 | -3.06 | -0.05 | -1.61 | 0.04 | -2.20 | -1.13 | -4.98 | |
| 1.27 | -3.05 | -0.30 | 3.21 | -0.88 | 0.43 | -0.28 | -0.29 | 0.07 | 1.42 | -2.55 | -0.48 | -1.52 | |
| 1.45 | -0.44 | 1.06 | -0.64 | 0.77 | 0.70 | 2.04 | 0.28 | 2.23 | 1.86 | 1.15 | 0.97 | 6.37 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.